Was transferred into helping to build Asymchem's new biologic division, AsymBio, outside of mainland China by supporting global clients with their biologics CMC needs which include mAbs, ADCs, plasmids, and mRNA. I also still support clients with small molecule and oligo/peptide needs.At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world’s top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we’ve built a knowledge and experience base that we’re ready to share.Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem.Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials'​ manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem’s proven team of experienced process and engineering teams has th eknowldge to help our clients get things done.Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.

Some of the most networked individuals in the local Boston biotech scene wanted to share their love of networking and biotech with the masses through a new networking organization. Unlike other biotech networking events, our events are focused on connecting the greater Boston area as opposed to solely focusing on the biotech community in Kendall Square. Events are open networking events with no agenda. As the organization develops, we plan to build out additional events focused on different aspects of the industry.First year accomplishments include:- Over 2,000 individuals came through our events since inception with an average attendance rate 80-90 people.- Key partnerships with companies such as Icon plc, Cambridge Healthtech Institute, Alcami, BPS Bioscience, McDermott Will & Emery, Wells Fargo Advisors, BioSurplus, Pepper Hamilton, and Boston Biomedical Innovation Center.- Nominated for an Xconomy AwardSecond year accomplishments include:- Key partnerships with companies such Alexion Pharmaceuticals, Salesforce, WeWork, McDermott Will & Emery, Medix, Cisbio, BioDirect, Halloran Consulting, Stratacuity, Biomere, Addgene, and BioSurplus, - Mailing list is over 4,000+ individuals and continues to grow as events host 100-150 people on average.

Supporting small to mid size clients with small molecule, oligonucleotide, and peptide CMC needs.Helped with establishing Asymchem's first lab outside of mainland China in Boston, which was setup to support early stage R&D for companies looking for CMC support.At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world’s top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we’ve built a knowledge and experience base that we’re ready to share.Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem.Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials'​ manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem’s proven team of experienced process and engineering teams has th eknowldge to help our clients get things done.Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.

•Developed and facilitated “lunch and learn” sessions with the numerous biomanufacturing consulting firms in the US to discuss Rentschler’s biologic service solutions regarding upstream/downstream analytical services and GMP manufacturing along with strategic partnerships for cell line development, formulation, and fill/finish services.•Prospected new accounts and developing relationships with existing accounts to help educate on Rentschler’s capabilities including global expansion with a new site in Milford, MA.•Hired to develop the East Coast market while simultaneously being a liaison between Germany and US sites.•Company presence for all US based conferences.•Assisted with all US marketing efforts due to my extensive experience in the biotech event space.

I apply my marketing expertise to every dimension of my position, including collaborating with both internal and external partners to deliver results on some of the top accounts for my company including with numerous Big Pharma accounts. I serve in a pivotal role, connecting key end users with vendors, and the currency of my relationships pays off daily.Whether I’m dropping into a lab to check on a piece of equipment, piloting a new app for internal inventory control, or consulting with industry KOLs to stay current on best practices, I never lose sight of my primary purpose: minimizing complexity for researchers who are advancing science in vital arenas. It matters to me that I’m contributing to disease treatment and eradication.My business acumen and keen eye for efficiency have produced impressive results, including:✔ Driving growth and revenue expansion by growing account revenue by 18% in 2014 and by additional 16% in 2015 while bringing in an average of $1.5M-$2M in new business each year. Generating and proposing deals in the range of $1K to over $1M while also offering over $500K in annual cost savings to clients and operating a 30-40% profit margin. ✔ New revenue streams for my company through Multi Vendor Service (MVS) channel✔ Dramatic reductions in equipment downtime, from months of inoperability to mere hours✔ Optimal functioning of >10,000 pieces of equipment through collaboration with >2,000 researchers and >100 service providersThe foundation of my success is my on-the-ground intel about personnel, equipment, and projects. When my team members want to know what’s happening in the field, I’m their first stop. Researchers, lab heads, and even vendor reps know to come to me immediately when problems arise. They know I’m the most efficient route to a solution. My stability—and my team’s depth of knowledge— has served as an anchor for these important contracts, and my alert radar has identified additional opportunities for my company.

The first time I attended an event with this group, I knew I’d found my crowd. Everyone has something to bring to the table—from a recent graduate to an established KOL—and I soak up each person’s story.I rapidly moved from an attendee in this group to a leadership role, and now I can staff an event or put together and lead a team for programs of ~200. With a membership roster of >4,000, we host monthly gatherings that range from topic-focused seminars to annual conferences.My role has expanded to include membership on teams that address:✔ Brand recognition✔ Expanded revenue streams through corporate sponsorships✔ Elevating attendanceI’ve recruited speakers, folded in nervous new attendees, and pitched in at the last minute when others weren’t available to staff their shifts. Whether I’m speaking with C-suite executives, patent attorneys, scientists, principal investigators, venture capitalists, recruiters, or marketing experts, I’m always learning with this group.

While I spent the years following my undergraduate studies as a contractor, I was committed to breaking into the biotech field, and it was meaningful to me that I was supporting research and treatment in important areas such as oncology and cystic fibrosis.I completed short-term assignments with dedication and enthusiasm, sometimes covering for people on maternity leave, others while there was a surge in need due in the FDA-approval process. Highlights included:• For Merrimack Pharmaceuticals—while I managed seemingly mundane administrative tasks such as scanning and archiving documents—I recognized the value of my contributions, and I took them seriously and performed them efficiently and accurately.• For Alnara Pharmaceuticals in 2010, I had the opportunity to support the FDA review of a cystic fibrosis treatment. As we worked to usher the appropriate paperwork through this Phase III drug approval process, I quickly learned the nuances of an in-house Electronic Document Management System and supported the integration of data storage systems.• For Genzyme Corporation, I had the good fortune to support 2 product lines: Carticel and Epicel. I also joined the team that managed the clinical trial launch for MACI, the next phase of Caritcel—offering a less-invasive treatment. I knew that accuracy and speed were vital for these initiatives, and I reviewed >600 batch records each month while addressing deviations using tracking software, Trackwise.• I had the opportunity to work for Genzyme in another assignment in 2008–2009 supporting the Seprafilm product line. It was there that I helped them integrate to Salesforce.• For ViviSource Laboratories, I cared for animal test subjects used for research by 5 early-stage, start-up biotech companies.

Although this position had been a stretch for me initially, I’d quickly developed a protocol for approaching sports fans and concertgoers at Fenway Park and other major venues. My goal: convince them to pose for photos and then purchase those photos as mementos. I’m proud of the fact that I surpassed the sales quota—within just a few weeks—securing >$1,500 in revenue and averaging >600 photos/game (double the quota!). I learned to give the opposing team a hard time or find another way to engage with spectators, and after I made a connection and took some great photos, I directed them to the sales page where they could make purchases. Along the way, I was able to attend some amazing events: the 2007 World Series, the 2008 NBA Finals, and Paul McCartney in concert. Plus, I learned to handle rejection and move past it.

What an honor it was to support blood drives and coordinate with local businesses in the Greater Boston area, including Cape Cod and southern Massachusetts, to elevate blood donations. While we faced only typical weather disasters such as severe winter storms during the time I served in this role, I knew how vital it was that our donations remain steady—and even increase. My job was to impress upon potential donors and corporate partners how necessary their contributions were—even without major headlines urging people to help. Some notable projects were blood drives with the New England Patriots and Red Sox.

At Judge Rotenberg Center, a residential facility that still provides intensive treatment for teens and young adults who have been diagnosed with serious mental health conditions and behavioral issues, I followed strict treatment protocols for patients who were sometimes aggressive and violent. Deaconess Cross Pointe Medical Center, an inpatient treatment center for patients with acute mental health needs and chemical dependency issues, provided me with the opportunity to learn structured treatment. Educating patients about their diagnoses was important, so I became very familiar with addiction, anxiety, depression, eating disorders, and other mental health conditions such as schizophrenia, bipolar disorder, and obsessive-compulsive disorder.